PMID: 9632275Jun 19, 1998Paper

Autologous bone marrow transplantation for childhood acute lymphoblastic leukaemia in Italy. AIEOP/FONOP-TMO Group. Italian Association of Paediatric Haemato-Oncology

Bone Marrow Transplantation
C MessinaG Scarzello

Abstract

From January 1984 to December 1994, ABMT was performed on 154 children (101 males, 53 females; median age 10, range 3-21 years) with ALL and registered for BMT by the AIEOP (Italian Association of Paediatric Haemato-Oncology). All patients were in CR: 98 were in 2nd CR and 56 were in >2nd CR. Fifteen children (9.7%) died of transplant-related mortality. Ninety-five patients (61.6%) relapsed at a median of 5 (range 1-42) months after ABMT. The 8-year EFS according to pre-BMT status was 34.6% (s.e. 4.9) for 2nd CR patients and 10.6% (s.e. 5.6) for patients in >2nd CR. By univariate analysis, site of relapse (isolated extramedullary (IE) vs BM: EFS = 68.5% vs 18.2%; P < 0.0001) and TBI containing regimen (TBI vs no TBI: EFS = 48.1 vs 15.4%; P = 0.0023) were significant factors for 2nd CR patients. When the 2nd CR subset with BM involvement was analysed, TBI became insignificant (EFS = 25.4 vs 11.8%). No factors influenced EFS in patients in >2nd CR. By multivariate analysis, site of relapse was the only significant factor in 2nd CR patients (P < 0.0001). In conclusion, ABMT is an effective treatment after one early IE relapse. Few patients can be rescued after BM relapse.

Citations

Oct 14, 2004·Springer Seminars in Immunopathology·Norbert-Claude Gorin
Jul 24, 2008·Bone Marrow Transplantation·E LaninoUNKNOWN Eurocord
Apr 28, 2010·Bone Marrow Transplantation·A BalduzziS Galimberti
Jan 11, 2007·Bone Marrow Transplantation·M MianoUNKNOWN Paediatric Diseases Working Party of the European Group for Blood and Marrow Transplantation
Nov 21, 2008·International Journal of Radiation Oncology, Biology, Physics·Maura MassiminoFranca Fossati-Bellani
Aug 14, 2009·International Journal of Cancer. Journal International Du Cancer·Sandra LoederSimone Fulda
Nov 9, 2005·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Theresa HahnPhilip L McCarthy
Apr 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gesche TallenArend von Stackelberg
Jul 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julio C BarredoA Kim Ritchey
Feb 19, 2002·Bone Marrow Transplantation·A BalduzziUNKNOWN Associazione Italiana Ematologia Oncologia Pediatrica-BMT Group
Apr 13, 2007·FEMS Immunology and Medical Microbiology·Govinda S VisvesvaraFrederick L Schuster
Jul 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·U M Saarinen-PihkalaUNKNOWN Nordic Society of Pediatric Hematology and Oncology

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.